{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["cancer bioenergy", "cancer metabolism", "cancer stem cells", "delocalized lipophilic cations", "drugs", "mitocans", "pharmacophores groups", "targeting mitochondria"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "33217901", "DateCompleted": {"Year": "2021", "Month": "03", "Day": "04"}, "DateRevised": {"Year": "2024", "Month": "08", "Day": "04"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "11", "Day": "18"}], "Language": ["eng"], "ELocationID": ["8684", "10.3390/ijms21228684"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "21", "Issue": "22", "PubDate": {"Year": "2020", "Month": "Nov", "Day": "18"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Medicinal Chemistry Targeting Mitochondria: From New Vehicles and Pharmacophore Groups to Old Drugs with Mitochondrial Activity.", "Abstract": {"AbstractText": ["Interest in tumor cell mitochondria as a pharmacological target has been rekindled in recent years. This attention is due in part to new publications documenting heterogenous characteristics of solid tumors, including anoxic and hypoxic zones that foster cellular populations with differentiating metabolic characteristics. These populations include tumor-initiating or cancer stem cells, which have a strong capacity to adapt to reduced oxygen availability, switching rapidly between glycolysis and oxidative phosphorylation as sources of energy and metabolites. Additionally, this cell subpopulation shows high chemo- and radioresistance and a high capacity for tumor repopulation. Interestingly, it has been shown that inhibiting mitochondrial function in tumor cells affects glycolysis pathways, cell bioenergy, and cell viability. Therefore, mitochondrial inhibition may be a viable strategy for eradicating cancer stem cells. In this context, medicinal chemistry research over the last decade has synthesized and characterized \"vehicles\" capable of transporting novel or existing pharmacophores to mitochondrial tumor cells, based on mechanisms that exploit the physicochemical properties of the vehicles and the inherent properties of the mitochondria. The pharmacophores, some of which have been isolated from plants and others, which were synthesized in the lab, are diverse in chemical nature. Some of these molecules are active, while others are prodrugs that have been evaluated alone or linked to mitochondria-targeted agents. Finally, researchers have recently described drugs with well-proven safety and efficacy that may exert a mitochondria-specific inhibitory effect in tumor cells through noncanonical mechanisms. The effectiveness of these molecules may be improved by linking them to mitochondrial carrier molecules. These promising pharmacological agents should be evaluated alone and in combination with classic chemotherapeutic drugs in clinical studies."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical and Molecular Pharmacology Program, Institute of Biomedical Sciences (ICBM), Faculty of Medicine, Universidad de Chile, Independencia 1027, Santiago 8380453, Chile."}], "LastName": "Catal\u00e1n", "ForeName": "Mabel", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Physiopathology Program, Institute of Biomedical Sciences (ICBM), Faculty of Medicine, Universidad de Chile, Independencia 1027, Santiago 8380453, Chile."}], "LastName": "Olmedo", "ForeName": "Ivonne", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute for Research in Dental Sciences (ICOD), Faculty of Dentistry, Universidad de Chile, Olivos 943, Santiago 8380544, Chile."}], "LastName": "Fa\u00fandez", "ForeName": "Jennifer", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute for Research in Dental Sciences (ICOD), Faculty of Dentistry, Universidad de Chile, Olivos 943, Santiago 8380544, Chile."}], "LastName": "Jara", "ForeName": "Jos\u00e9 A", "Initials": "JA"}], "GrantList": [{"GrantID": "11180533", "Agency": "Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico", "Country": ""}, {"GrantID": "1180296", "Agency": "Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico", "Country": ""}, {"GrantID": "11170962", "Agency": "Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico", "Country": ""}, {"GrantID": "11160281", "Agency": "Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Drug Carriers"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Drug Carriers"}, {"QualifierName": ["drug effects"], "DescriptorName": "Drug Resistance, Neoplasm"}, {"QualifierName": ["drug effects"], "DescriptorName": "Glycolysis"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism", "pathology"], "DescriptorName": "Mitochondria"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Phosphorylation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Radiation Tolerance"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Bock F.J., Tait S.W.G. Mitochondria as multifaceted regulators of cell death. Nat. Rev. Mol. Cell Biol. 2020;21:85\u2013100. doi: 10.1038/s41580-019-0173-8.", "ArticleIdList": ["10.1038/s41580-019-0173-8", "31636403"]}, {"Citation": "Vidali S., Aminzadeh S., Lambert B., Rutherford T., Sperl W., Kofler B., Feichtinger R.G. Mitochondria: The ketogenic diet\u2014A metabolism-based therapy. Int. J. Biochem. Cell Biol. 2015;63:55\u201359. doi: 10.1016/j.biocel.2015.01.022.", "ArticleIdList": ["10.1016/j.biocel.2015.01.022", "25666556"]}, {"Citation": "De Berardinis R.J., Chandel N.S. Fundamentals of cancer metabolism. Sci. Adv. 2016;2 doi: 10.1126/sciadv.1600200.", "ArticleIdList": ["10.1126/sciadv.1600200", "PMC4928883", "27386546"]}, {"Citation": "Han Y., Cho U., Kim S., Park I.S., Cho J.H., Dhanasekaran D.N., Song Y.S. Tumour microenvironment on mitochondrial dynamics and chemoresistance in cancer. Free Radic. Res. 2018;52:1271\u20131287. doi: 10.1080/10715762.2018.1459594.", "ArticleIdList": ["10.1080/10715762.2018.1459594", "29607684"]}, {"Citation": "Begg K., Tavassoli M. Inside the hypoxic tumour: Reprogramming of the DDR and radioresistance. Cell Death Discov. 2020;6 doi: 10.1038/s41420-020-00311-0.", "ArticleIdList": ["10.1038/s41420-020-00311-0", "PMC7434912", "32864165"]}, {"Citation": "Carnero A., Lleonart M. The hypoxic microenvironment: A determinant of cancer stem cell evolution. Inside Cell. 2016;1:96\u2013105. doi: 10.1002/bies.201670911.", "ArticleIdList": ["10.1002/bies.201670911", "27417124"]}, {"Citation": "Past\u00f2 A., Bellio C., Pilotto G., Ciminale V., Silic-Benussi M., Guzzo G., Rasola A., Frasson C., Nardo G., Zulato E., et al. Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation. Oncotarget. 2014;5:4305\u20134319. doi: 10.18632/oncotarget.2010.", "ArticleIdList": ["10.18632/oncotarget.2010", "PMC4147325", "24946808"]}, {"Citation": "Viale A., Corti D., Draetta G.F. Tumors and mitochondrial respiration: A neglected connection. Cancer Res. 2015;75:3685\u20133686. doi: 10.1158/0008-5472.CAN-15-0491.", "ArticleIdList": ["10.1158/0008-5472.CAN-15-0491", "26374463"]}, {"Citation": "Warburg O. On Respiratory Impairment in Cancer Cells. Science. 1956;124:267\u2013272.", "ArticleIdList": ["13351639"]}, {"Citation": "Wallace D.C. Mitochondria and cancer. Nat. Rev. Cancer. 2012;12:685\u2013698. doi: 10.1038/nrc3365.", "ArticleIdList": ["10.1038/nrc3365", "PMC4371788", "23001348"]}, {"Citation": "Weinberg S.E., Chandel N.S. Targeting mitochondria metabolism for cancer therapy Samuel. Nat. Chem. Biol. 2015;11:9\u201315. doi: 10.1038/nchembio.1712.", "ArticleIdList": ["10.1038/nchembio.1712", "PMC4340667", "25517383"]}, {"Citation": "Tan A.S., Baty J.W., Dong L.F., Bezawork-Geleta A., Endaya B., Goodwin J., Bajzikova M., Kovarova J., Peterka M., Yan B., et al. Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA. Cell Metab. 2015;21:81\u201394. doi: 10.1016/j.cmet.2014.12.003.", "ArticleIdList": ["10.1016/j.cmet.2014.12.003", "25565207"]}, {"Citation": "Cai F.F., Kohler C., Zhang B., Chen W.J., Barekati Z., Garritsen H.S.P., Lenner P., Toniolo P., Zhang J.J., Zhong X.Y. Mutations of mitochondrial DNA as potential biomarkers in breast cancer. Anticancer Res. 2011;31:4267\u20134271.", "ArticleIdList": ["22199290"]}, {"Citation": "Fiaschi T., Marini A., Giannoni E., Taddei M.L., Gandellini P., De Donatis A., Lanciotti M., Serni S., Cirri P., Chiarugi P. Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay. Cancer Res. 2012;72:5130\u20135140. doi: 10.1158/0008-5472.CAN-12-1949.", "ArticleIdList": ["10.1158/0008-5472.CAN-12-1949", "22850421"]}, {"Citation": "Gammon L., Mackenzie I.C. Roles of hypoxia, stem cells and epithelial-mesenchymal transition in the spread and treatment resistance of head and neck cancer. J. Oral Pathol. Med. 2016;45:77\u201382. doi: 10.1111/jop.12327.", "ArticleIdList": ["10.1111/jop.12327", "25952002"]}, {"Citation": "Magr\u00ec A., Reina S., De Pinto V. VDAC1 as pharmacological target in cancer and neurodegeneration: Focus on its role in apoptosis. Front. Chem. 2018;6:108. doi: 10.3389/fchem.2018.00108.", "ArticleIdList": ["10.3389/fchem.2018.00108", "PMC5897536", "29682501"]}, {"Citation": "Shoshan-barmatz V., De Pinto V., Zweckstetter M., Raviv Z., Keinan N., Arbel N. Molecular Aspects of Medicine VDAC, a multi-functional mitochondrial protein regulating cell life and death. Mol. Asp. Med. 2010;31:227\u2013285. doi: 10.1016/j.mam.2010.03.002.", "ArticleIdList": ["10.1016/j.mam.2010.03.002", "20346371"]}, {"Citation": "Liu C., Wang X., Zhang Y. The Roles of HK2 on Tumorigenesis of Cervical Cancer. Technol. Cancer Res. Treat. 2019;18:1533033819871306. doi: 10.1177/1533033819871306.", "ArticleIdList": ["10.1177/1533033819871306", "PMC6751531", "31530094"]}, {"Citation": "Ralph S.J., Neuzil J. Mitochondria as targets for cancer therapy. Mol. Nutr. Food Res. 2009;53:9\u201328. doi: 10.1002/mnfr.200800044.", "ArticleIdList": ["10.1002/mnfr.200800044", "19123183"]}, {"Citation": "Samuel B., Lampidis T., McIsaac R., Bo Chen L. Anticarcinoma activity in vivo of rhodamine 123, a Mitochondrial-Specific Dye. Science. 1983;222:169\u2013172.", "ArticleIdList": ["6623064"]}, {"Citation": "Murphy M.P. Biochimica et Biophysica Acta Targeting lipophilic cations to mitochondria. Biochim. Biophys. Acta Bioenerg. 2008;1777:1028\u20131031. doi: 10.1016/j.bbabio.2008.03.029.", "ArticleIdList": ["10.1016/j.bbabio.2008.03.029", "18439417"]}, {"Citation": "Rohlena J., Dong L.-F., Ralph S.J., Neuzil J. Anticancer Drugs Targeting the Mitochondrial Electron Transport Chain. Antioxid. Redox Signal. 2011;15:2951\u20132974. doi: 10.1089/ars.2011.3990.", "ArticleIdList": ["10.1089/ars.2011.3990", "21777145"]}, {"Citation": "Jara J.A., Castro-Castillo V., Saavedra-Olavarr\u00eda J., Peredo L., Pavanni M., Ja\u00f1a F., Letelier M.E., Parra E., Becker M.I., Morello A., et al. Antiproliferative and uncoupling effects of delocalized, lipophilic, cationic gallic acid derivatives on cancer cell lines. Validation in vivo in singenic mice. J. Med. Chem. 2014;57:2440\u20132454. doi: 10.1021/jm500174v.", "ArticleIdList": ["10.1021/jm500174v", "24568614"]}, {"Citation": "Sandoval-Acu\u00f1a C., Fuentes-Retamal S., Guzm\u00e1n-Rivera D., Peredo-Silva L., Madrid-Rojas M., Rebolledo S., Castro-Castillo V., Pavani M., Catal\u00e1n M., Maya J.D., et al. Destabilization of mitochondrial functions as a target against breast cancer progression: Role of TPP+-linked-polyhydroxybenzoates. Toxicol. Appl. Pharmacol. 2016;309:2\u201314. doi: 10.1016/j.taap.2016.08.018.", "ArticleIdList": ["10.1016/j.taap.2016.08.018", "27554043"]}, {"Citation": "Panina S.B., Baran N., Brasil da Costa F.H., Konopleva M., Kirienko N.V. A mechanism for increased sensitivity of acute myeloid leukemia to mitotoxic drugs. Cell Death Dis. 2019;10 doi: 10.1038/s41419-019-1851-3.", "ArticleIdList": ["10.1038/s41419-019-1851-3", "PMC6692368", "31409768"]}, {"Citation": "Wang J., Li J., Xiao Y., Fu B., Qin Z. TPP-based mitocans: A potent strategy for anticancer drug design. RSC Med. Chem. 2020;11:858\u2013875. doi: 10.1039/C9MD00572B.", "ArticleIdList": ["10.1039/C9MD00572B", "PMC7489259", "33479681"]}, {"Citation": "Bergers G., Benjamin L.E. Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer. 2003;3:401\u2013410. doi: 10.1038/nrc1093.", "ArticleIdList": ["10.1038/nrc1093", "12778130"]}, {"Citation": "Thomlinson R.H., Gray L.H. The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy. Br. J. Cancer. 1955;9:539\u2013549. doi: 10.1038/bjc.1955.55.", "ArticleIdList": ["10.1038/bjc.1955.55", "PMC2073776", "13304213"]}, {"Citation": "Najafi M., Farhood B., Mortezaee K., Kharazinejad E., Majidpoor J. Hypoxia in solid tumors: A key promoter of cancer stem cell (CSC) resistance. J. Cancer Res. Clin. Oncol. 2020;146:19\u201331. doi: 10.1007/s00432-019-03080-1.", "ArticleIdList": ["10.1007/s00432-019-03080-1", "31734836"]}, {"Citation": "Hirayama A., Kami K., Sugimoto M., Sugawara M., Toki N., Onozuka H., Kinoshita T., Saito N., Ochiai A., Tomita M., et al. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res. 2009;69:4918\u20134925. doi: 10.1158/0008-5472.CAN-08-4806.", "ArticleIdList": ["10.1158/0008-5472.CAN-08-4806", "19458066"]}, {"Citation": "Zhang B., Xie Z., Li B. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis. Gene. 2019;689:76\u201383. doi: 10.1016/j.gene.2018.12.006.", "ArticleIdList": ["10.1016/j.gene.2018.12.006", "30552981"]}, {"Citation": "Otto Warburg B., Wind F., Negelein N. The metabolism of tumors in the body. J. Gen. Physiol. 1923;309:397\u2013519. doi: 10.1085/jgp.8.6.519.", "ArticleIdList": ["10.1085/jgp.8.6.519", "PMC2140820", "19872213"]}, {"Citation": "Birsoy K., Possemato R., Lorbeer F.K., Bayraktar E.C., Thiru P., Yucel B., Wang T., Chen W.W., Clish C.B., Sabatini D.M. Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides. Nature. 2014;508:108\u2013112. doi: 10.1038/nature13110.", "ArticleIdList": ["10.1038/nature13110", "PMC4012432", "24670634"]}, {"Citation": "Zhang X., De Milito A., Demiroglu-Zergeroglu A., Gullbo J., D\u2019Arcy P., Linder S. Eradicating Quiescent Tumor Cells by Targeting Mitochondrial Bioenergetics. Trends Cancer. 2016;2:657\u2013663. doi: 10.1016/j.trecan.2016.10.009.", "ArticleIdList": ["10.1016/j.trecan.2016.10.009", "28741504"]}, {"Citation": "Nguyen C., Pandey S. Exploiting mitochondrial vulnerabilities to trigger apoptosis selectively in cancer cells. Cancers. 2019;11:916. doi: 10.3390/cancers11070916.", "ArticleIdList": ["10.3390/cancers11070916", "PMC6678564", "31261935"]}, {"Citation": "Durazzo A., Lucarini M., Souto E.B., Cicala C., Caiazzo E., Izzo A.A., Novellino E., Santini A. Polyphenols: A concise overview on the chemistry, occurrence, and human health. Phyther. Res. 2019;33:2221\u20132243. doi: 10.1002/ptr.6419.", "ArticleIdList": ["10.1002/ptr.6419", "31359516"]}, {"Citation": "Pot\u00ec F., Santi D., Spaggiari G., Zimetti F., Zanotti I. Polyphenol health effects on cardiovascular and neurodegenerative disorders: A review and meta-analysis. Int. J. Mol. Sci. 2019;20:351. doi: 10.3390/ijms20020351.", "ArticleIdList": ["10.3390/ijms20020351", "PMC6359281", "30654461"]}, {"Citation": "Gu H.-F., Mao X.-Y., Du M. Prevention of breast cancer by dietary polyphenols\u2014Role of cancer stem cells Hao-Feng. Crit. Rev. Food Sci. Nutr. 2020;60:810\u2013825. doi: 10.1080/10408398.2018.1551778.", "ArticleIdList": ["10.1080/10408398.2018.1551778", "PMC6625949", "30632783"]}, {"Citation": "Mileo A.M., Miccadei S. Polyphenols as Modulator of Oxidative Stress in Cancer Disease: New Therapeutic Strategies. Oxid. Med. Cell. Longev. 2016;2016 doi: 10.1155/2016/6475624.", "ArticleIdList": ["10.1155/2016/6475624", "PMC4663347", "26649142"]}, {"Citation": "Ki W.L., Hyong J.L. The roles of polyphenols in cancer chemoprevention. BioFactors. 2006;26:105\u2013121. doi: 10.1002/biof.5520260202.", "ArticleIdList": ["10.1002/biof.5520260202", "16823097"]}, {"Citation": "Asensi M., Ortega A., Mena S., Feddi F., Estrela J.M. Natural polyphenols in cancer therapy. Crit. Rev. Clin. Lab. Sci. 2011;48:197\u2013216. doi: 10.3109/10408363.2011.631268.", "ArticleIdList": ["10.3109/10408363.2011.631268", "22141580"]}, {"Citation": "Aggarwal V., Tuli H.S., Varol A., Thakral F., Yerer M.B., Sak K., Varol M., Jain A., Khan M.A., Sethi G. Role of reactive oxygen species in cancer progression: Molecular mechanisms and recent advancements. Biomolecules. 2019;9:735. doi: 10.3390/biom9110735.", "ArticleIdList": ["10.3390/biom9110735", "PMC6920770", "31766246"]}, {"Citation": "Russo G.L., Tedesco I., Spagnuolo C., Russo M. Antioxidant polyphenols in cancer treatment: Friend, foe or foil? Semin. Cancer Biol. 2017;46:1\u201313. doi: 10.1016/j.semcancer.2017.05.005.", "ArticleIdList": ["10.1016/j.semcancer.2017.05.005", "28511887"]}, {"Citation": "Taparia S.S., Khanna A. Procyanidin-rich extract of natural cocoa powder causes ROS-mediated caspase-3 dependent apoptosis and reduction of pro-MMP-2 in epithelial ovarian carcinoma cell lines. Biomed. Pharmacol. 2016;83:130\u2013140. doi: 10.1016/j.biopha.2016.06.019.", "ArticleIdList": ["10.1016/j.biopha.2016.06.019", "27470560"]}, {"Citation": "Ahmed S., Khan H., Fratantonio D., Hasan M.M., Sharifi S., Fathi N., Ullah H., Rastrelli L. Apoptosis induced by luteolin in breast cancer: Mechanistic and therapeutic perspectives. Phytomedicine. 2019;59 doi: 10.1016/j.phymed.2019.152883.", "ArticleIdList": ["10.1016/j.phymed.2019.152883", "30986716"]}, {"Citation": "Cook M.T. Mechanism of metastasis suppression by luteolin in breast cancer. Breast Cancer Targets Ther. 2018;10:89\u2013100. doi: 10.2147/BCTT.S144202.", "ArticleIdList": ["10.2147/BCTT.S144202", "PMC6003288", "29928143"]}, {"Citation": "Li Z., Zhang Y., Chen L., Li H. The dietary compound luteolin inhibits pancreatic cancer growth by targeting BCL-2. Food Funct. 2018;9:3018\u20133027. doi: 10.1039/C8FO00033F.", "ArticleIdList": ["10.1039/C8FO00033F", "29770817"]}, {"Citation": "Kang K.A., Piao M.J., Ryu Y.S., Hyun Y.J., Park J.E., Shilnikova K., Zhen A.X., Kang H.K., Koh Y.S., Jeong Y.J., et al. Luteolin induces apoptotic cell death via antioxidant activity in human colon cancer cells. Int. J. Oncol. 2017;51:1169\u20131178. doi: 10.3892/ijo.2017.4091.", "ArticleIdList": ["10.3892/ijo.2017.4091", "28791416"]}, {"Citation": "Pandurangan A.K., Ananda Sadagopan S.K., Dharmalingam P., Ganapasam S. Luteolin, a bioflavonoid inhibits Azoxymethane-induced colorectal cancer through activation of Nrf2 signaling. Toxicol. Mech. Methods. 2014;24:13\u201320. doi: 10.3109/15376516.2013.843111.", "ArticleIdList": ["10.3109/15376516.2013.843111", "24024667"]}, {"Citation": "Pandurangan A.K., Esa N.M. Luteolin, a bioflavonoid inhibits colorectal cancer through modulation of multiple signaling pathways: A review. Asian Pac. J. Cancer Prev. 2014;15:5501\u20135508. doi: 10.7314/APJCP.2014.15.14.5501.", "ArticleIdList": ["10.7314/APJCP.2014.15.14.5501", "25081655"]}, {"Citation": "Wang Q., Wang H., Jia Y., Pan H., Ding H. Luteolin induces apoptosis by ROS/ER stress and mitochondrial dysfunction in gliomablastoma. Cancer Chemother. Pharmacol. 2017;79:1031\u20131041. doi: 10.1007/s00280-017-3299-4.", "ArticleIdList": ["10.1007/s00280-017-3299-4", "28393257"]}, {"Citation": "Dong W., Lin Y., Cao Y., Liu Y., Xie X., Gu W. Luteolin induce myelodisplatic syndrome-derived cell apoptosis via p53-dependent mitochondrial signaling pathway mediated by reactive oxygen species. Int. J. Mol. Med. 2018;42:1106\u20131115.", "ArticleIdList": ["29786746"]}, {"Citation": "Seydi E., Salimi A., Rasekh H.R., Mohsenifar Z., Pourahmad J. Selective Cytotoxicity of Luteolin and Kaempferol on Cancerous Hepatocytes Obtained from Rat Model of Hepatocellular Carcinoma: Involvement of ROS-Mediated Mitochondrial Targeting. Nutr. Cancer. 2018;70:594\u2013604. doi: 10.1080/01635581.2018.1460679.", "ArticleIdList": ["10.1080/01635581.2018.1460679", "29693446"]}, {"Citation": "Kamaraj S., Ramakrishnan G., Anandakumar P., Jagan S., Devaki T. Antioxidant and anticancer efficacy of hesperidin in benzo(a)pyrene induced lung carcinogenesis in mice. Investig. New Drugs. 2009;27:214\u2013222. doi: 10.1007/s10637-008-9159-7.", "ArticleIdList": ["10.1007/s10637-008-9159-7", "18704264"]}, {"Citation": "Zhang J., Wu D., Vikash, Song J., Wang J., Yi J., Dong W. Hesperetin Induces the Apoptosis of Gastric Cancer Cells via Activating Mitochondrial Pathway by Increasing Reactive Oxygen Species. Dig. Dis. Sci. 2015;60:2985\u20132995. doi: 10.1007/s10620-015-3696-7.", "ArticleIdList": ["10.1007/s10620-015-3696-7", "25972151"]}, {"Citation": "Feie L., Xi C., Bing X., Zhou H. Curcumin induce p53-independent necrosis in H1299 cells via a mitochondria-associated pathway. Mol. Med. Rep. 2015;12:7806\u20137814.", "ArticleIdList": ["26460892"]}, {"Citation": "Wang C., Song X., Shang M., Zou W., Zhang M., Wei H., Shao H. Curcumin exerts cytotoxicity dependent on reactive oxygen species accumulation in non-small-cell lung cancer cells. Future Oncol. 2019;15:1243\u20131253. doi: 10.2217/fon-2018-0708.", "ArticleIdList": ["10.2217/fon-2018-0708", "30843426"]}, {"Citation": "Wang K., Fan H., Chen Q., Ma G., Zhu M., Zhang X., Zhang Y., Yu J. Curcumin inhibits aerobic glycolysis and induces mitochondrial-mediated apoptosis through hexokinase II in human colorectal cancer cells in vitro. Anticancer Drugs. 2015;26:15\u201324. doi: 10.1097/CAD.0000000000000132.", "ArticleIdList": ["10.1097/CAD.0000000000000132", "25229889"]}, {"Citation": "Ho C.-C., Huang A.-C., Yu C.-S., Lien J.-C., Wu S.-H., Huang Y.-P., Huang H.-Y., Kuo J.-H., Liao W.-Y., Yang J.-S., et al. Ellagic Acid Induces Apoptosis in TSGH8301 Human Bladder Cancer Cells Through the Endoplasmic Reticulum Stress- and Mitochondria-Dependent Signaling Pathways. Environ. Toxicol. 2014;29:1262\u20131274. doi: 10.1002/tox.21857.", "ArticleIdList": ["10.1002/tox.21857", "23554011"]}, {"Citation": "Alfredsson C.F., Ding M., Liang Q.L., Sundstr\u00f6m B.E., N\u00e5nberg E. Ellagic acid induces a dose- and time-dependent depolarization of mitochondria and activation of caspase-9 and -3 in human neuroblastoma cells. Biomed. Pharmacol. 2014;68:129\u2013135. doi: 10.1016/j.biopha.2013.08.010.", "ArticleIdList": ["10.1016/j.biopha.2013.08.010", "24051122"]}, {"Citation": "Salimi A., Roudkenar M.H., Sadeghi L., Mohseni A., Seydi E., Pirahmadi N., Pourahmad J. Ellagic acid, a polyphenolic compound, selectively induces ROS-mediated apoptosis in cancerous B-lynphocytes of CLL patients by directly targeting mitochondria. Redox Biol. 2015;6:461\u2013471.", "ArticleIdList": ["PMC4588415", "26418626"]}, {"Citation": "Li W., Shi Y., Wang R., Pan L., Ma L., Jin F. Resveratrol promotes the sensitivity of small-cell lung cancer H446 cells to cisplatin by regulating intrinsic apoptosis. Int. J. Oncol. 2018;53:2123\u20132130. doi: 10.3892/ijo.2018.4533.", "ArticleIdList": ["10.3892/ijo.2018.4533", "30132509"]}, {"Citation": "Kumar S.J., Eroglu E., Stokes J.A., Scissum-Gunn K., Saldanha S.N., Singh U.P., Manne U., Ponnazhagan S., Mishra M.K. Resveratrol induces mitochondria-mediated, caspaseindependent apoptosis in murine prostate cancer cells. Oncotarget. 2017;8:20895\u201320908. doi: 10.18632/oncotarget.14947.", "ArticleIdList": ["10.18632/oncotarget.14947", "PMC5400554", "28157696"]}, {"Citation": "Rodr\u00edguez-Enr\u00edquez S., Pacheco-Vel\u00e1zquez S.C., Mar\u00edn-Hern\u00e1ndez \u00c1., Gallardo-P\u00e9rez J.C., Robledo-Cadena D.X., Hern\u00e1ndez-Res\u00e9ndiz I., Garc\u00eda-Garc\u00eda J.D., Belmont-D\u00edaz J., L\u00f3pez-Marure R., Hern\u00e1ndez-Esquivel L., et al. Resveratrol inhibits cancer cell proliferation by impairing oxidative phosphorylation and inducing oxidative stress. Toxicol. Appl. Pharmacol. 2019;370:65\u201377. doi: 10.1016/j.taap.2019.03.008.", "ArticleIdList": ["10.1016/j.taap.2019.03.008", "30878505"]}, {"Citation": "Lee J.H., Jeong Y.J., Lee S.W., Kim D., Oh S.J., Lim H.S., Oh H.K., Kim S.H., Kim W.J., Jung J.Y. EGCG induces apoptosis in human laryngeal epidermoid carcinoma Hep2 cells via mitochondria with the release of apoptosis-inducing factor and endonuclease G. Cancer Lett. 2010;290:68\u201375. doi: 10.1016/j.canlet.2009.08.027.", "ArticleIdList": ["10.1016/j.canlet.2009.08.027", "19781850"]}, {"Citation": "Qanungo S., Das M., Haldar S., Basu A. Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells. Carcinogenesis. 2005;26:958\u2013967. doi: 10.1093/carcin/bgi040.", "ArticleIdList": ["10.1093/carcin/bgi040", "15705601"]}, {"Citation": "Li W., Nie S., Yu Q., Xie M.Y. (-)-Epigallocatechin-3-Gallate Induces Apoptosis of Human Hepatoma Cells By Mitochondrial Pathways Related To Reactive Oxygen Species. J. Agric. Food Chem. 2009;57:6685\u20136691. doi: 10.1021/jf901396f.", "ArticleIdList": ["10.1021/jf901396f", "19601628"]}, {"Citation": "Sun Z., Yu G., Huang C., Bu L., Liu J. Hypoxia induces TFE3 expression in head and neck squamous cell carcinoma. Oncotarget. 2016;7 doi: 10.18632/oncotarget.7309.", "ArticleIdList": ["10.18632/oncotarget.7309", "PMC4905500", "26872381"]}, {"Citation": "Valenti D., De Bari L., Manente G.A., Rossi L., Mutti L., Moro L., Vacca R.A. Negative modulation of mitochondrial oxidative phosphorylation by epigallocatechin-3 gallate leads to growth arrest and apoptosis in human malignant pleural mesothelioma cells. Biochim. Biophys. Acta Mol. Basis Dis. 2013;1832:2085\u20132096. doi: 10.1016/j.bbadis.2013.07.014.", "ArticleIdList": ["10.1016/j.bbadis.2013.07.014", "23911347"]}, {"Citation": "Chen A., Jiang P., Zeb F., Wu X., Xu C., Chen L., Feng Q. EGCG regulates CTR1 expression through its pro-oxidative property in non-small-cell lung cancer cells. J. Cell. Physiol. 2020:1\u201312. doi: 10.1002/jcp.29451.", "ArticleIdList": ["10.1002/jcp.29451", "31943177"]}, {"Citation": "Sang S., Lee M.J., Hou Z., Ho C.T., Yang C.S. Stability of tea polyphenol (-)-epigallocatechin-3-gallate and formation of dimers and epimers under common experimental conditions. J. Agric. Food Chem. 2005;53:9478\u20139484. doi: 10.1021/jf0519055.", "ArticleIdList": ["10.1021/jf0519055", "16302765"]}, {"Citation": "Gorlach S., Fichna J., Lewandowska U. Polyphenols as mitochondria-targeted anticancer drugs. Cancer Lett. 2015;366:141\u2013149. doi: 10.1016/j.canlet.2015.07.004.", "ArticleIdList": ["10.1016/j.canlet.2015.07.004", "26185003"]}, {"Citation": "Moini H., Arroyo A., Vaya J., Packer L. Bioflavonoid effects on the mitochondrial respiratory electron transport chain and cytochrome c redox state. Redox Rep. 1999;4:35\u201341. doi: 10.1179/135100099101534729.", "ArticleIdList": ["10.1179/135100099101534729", "10714274"]}, {"Citation": "Tewari D., Ahmed T., Chirasani V.R., Singh P.K., Maji S.K., Senapati S., Bera A.K. Modulation of the mitochondrial voltage dependent anion channel (VDAC) by curcumin. Biochim. Biophys. Acta Biomembr. 2015;1848:151\u2013158. doi: 10.1016/j.bbamem.2014.10.014.", "ArticleIdList": ["10.1016/j.bbamem.2014.10.014", "25459681"]}, {"Citation": "Gao F., Li M., Liu W.-B., Zhou Z.S., Zhang R., Li J.L., Zhou K.C. Epigallocatechin gallate inhibits human tongue carcinoma cells via HK2-mediated glycolysis. Oncol. Rep. 2015;33:1533\u20131539. doi: 10.3892/or.2015.3727.", "ArticleIdList": ["10.3892/or.2015.3727", "25591943"]}, {"Citation": "Li S., Li J., Dai W., Zhang Q., Feng J., Wu L., Liu T., Yu Q., Xu S., Wang W., et al. Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death. Br. J. Cancer. 2017;117:1518\u20131528. doi: 10.1038/bjc.2017.323.", "ArticleIdList": ["10.1038/bjc.2017.323", "PMC5680469", "28926527"]}, {"Citation": "Wu H., Pan L., Gao C., Xu H., Li Y., Zhang L., Ma L., Sun X., Qin H. Quercetin Inhibits the Proliferation of Glycolysis-Addicted HCC Cells by Reducing Hexokinase 2 and Akt-mTOR Pathway. Molecules. 2019;24:1993. doi: 10.3390/molecules24101993.", "ArticleIdList": ["10.3390/molecules24101993", "PMC6572074", "31137633"]}, {"Citation": "Li W., Ma X., Li N., Liu H., Dong Q., Zhang J., Yang C., Liu Y., Liang Q., Zhang S., et al. Resveratrol inhibits Hexokinases II mediated glycolysis in non-small cell lung cancer via targeting Akt signaling pathway. Exp. Cell Res. 2016;349:320\u2013327. doi: 10.1016/j.yexcr.2016.11.002.", "ArticleIdList": ["10.1016/j.yexcr.2016.11.002", "27829129"]}, {"Citation": "Garc\u00eda-Aranda M., P\u00e9rez-Ruiz E., Redondo M. Bcl-2 inhibition to overcome resistance to chemo-and immunotherapy. Int. J. Mol. Sci. 2018;19:3950. doi: 10.3390/ijms19123950.", "ArticleIdList": ["10.3390/ijms19123950", "PMC6321604", "30544835"]}, {"Citation": "Verma S., Singh A., Kumari A., Tyagi C., Goyal S., Jamal S., Grover A. Natural polyphenolic inhibitors against the antiapoptotic BCL-2. J. Recept. Signal Transduct. 2017;37:391\u2013400. doi: 10.1080/10799893.2017.1298129.", "ArticleIdList": ["10.1080/10799893.2017.1298129", "28264627"]}, {"Citation": "Wang H., Luo Y., Qiao T., Wu Z., Huang Z. Luteolin sensitizes the antitumor effect of cisplatin in drug-resistant ovarian cancer via induction of apoptosis and inhibition of cell migration and invasion. J. Ovarian Res. 2018;11:1\u201312. doi: 10.1186/s13048-018-0468-y.", "ArticleIdList": ["10.1186/s13048-018-0468-y", "PMC6241043", "30454003"]}, {"Citation": "Zhang L., Zhou Y., Chen K., Shi P., Li Y., Deng M., Jiang Z., Wang X., Li P., Xu B. The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells. Target. Oncol. 2017;12:677\u2013687. doi: 10.1007/s11523-017-0509-2.", "ArticleIdList": ["10.1007/s11523-017-0509-2", "28710745"]}, {"Citation": "Fong D., Chan M.M. Mitochondria as Targets for Phytochemicals in Cancer Prevention and Therapy. Springer; Berlin, Germany: 2013. Dietary Phytochemicals Target Cancer Stem Cells for Cancer Chemoprevention; pp. 85\u2013125."}, {"Citation": "Garc\u00eda-Heredia J.M., Carnero A. Role of Mitochondria in Cancer Stem Cell Resistance. Cells. 2020;9:1693. doi: 10.3390/cells9071693.", "ArticleIdList": ["10.3390/cells9071693", "PMC7407626", "32679735"]}, {"Citation": "Jara J.A., Rojas D., Castro-Castillo V., Fuentes-Retamal S., Sandoval-Acu\u00f1a C., Parra E., Pavani M., Maya J.D., Ferreira J., Catal\u00e1n M. Novel benzoate-lipophilic cations selectively induce cell death in human colorectal cancer cell lines. Toxicol. In Vitro. 2020;65:104814. doi: 10.1016/j.tiv.2020.104814.", "ArticleIdList": ["10.1016/j.tiv.2020.104814", "32112803"]}, {"Citation": "Lichtshteint D., Kabackt H.R., Blumet A.J. Use of a Lipophilic Cation for Determination of Membrane Potential in Neuroblastoma-Glioma Hybrid Cell Suspension. Proc. Natl. Acad. Sci. USA. 1979;76:650\u2013654. doi: 10.1073/pnas.76.2.650.", "ArticleIdList": ["10.1073/pnas.76.2.650", "PMC383006", "284390"]}, {"Citation": "Fantin V.R., St-Pierre J., Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell. 2006:425\u2013434. doi: 10.1016/j.ccr.2006.04.023.", "ArticleIdList": ["10.1016/j.ccr.2006.04.023", "16766262"]}, {"Citation": "Bagkos G., Koufopoulos K., Piperi C. A new model for mitochondrial membrane potential production and storage. Med. Hypotheses. 2014;83:175\u2013181. doi: 10.1016/j.mehy.2014.05.001.", "ArticleIdList": ["10.1016/j.mehy.2014.05.001", "24907229"]}, {"Citation": "Zielonka J., Sikora A., Hardy M., Ouari O., Vasquez-Vivar J., Cheng G., Lopez M., Kalyanaraman B. Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications. Chem. Rev. 2018;117:10043\u201310120. doi: 10.1021/acs.chemrev.7b00042.", "ArticleIdList": ["10.1021/acs.chemrev.7b00042", "PMC5611849", "28654243"]}, {"Citation": "Koya K., Li Y., Wang H., Ukai T., Tatsuta N., Kawakami M., Shishido T., Chen L.B. MKT-077, a Novel Rhodacyanine Dye in Clinical Trials, Exhibits Anticarcinoma Activity in Preclinical Studies Based on Selective Mitochondrial Accumulation. Cancer Res. 1996;56:538\u2013544.", "ArticleIdList": ["8564968"]}, {"Citation": "Propper D.J., Braybrooke J.P., Taylor D.J., Lodi R., Styles P., Cramer J.A., Collins W.C.J., Levitt N.C., Talbot D.C., Ganesan T.S., et al. Phase I trial of the selective mitochondrial toxin MKT 077 in chemo-resistant solid tumours. Ann. Oncol. 1999;10:923\u2013927. doi: 10.1023/A:1008336904585.", "ArticleIdList": ["10.1023/A:1008336904585", "10509153"]}, {"Citation": "Jones L.W., Narayan K.S., Shapiro C.E., Sweatman T.W. Rhodamine-123: Therapy for Hormone Refractory Prostate Cancer, A Phase I Clinical Trial. J. Chemother. 2005;17:435\u2013440. doi: 10.1179/joc.2005.17.4.435.", "ArticleIdList": ["10.1179/joc.2005.17.4.435", "16167524"]}, {"Citation": "Fantin V.R., Berardi M.J., Scorrano L., Korsmeyer S.J., Leder P. A novel mitochondriotoxic small molecule that selectively inhibits tumor cell growth. Cancer Cell. 2002;2:29\u201342. doi: 10.1016/S1535-6108(02)00082-X.", "ArticleIdList": ["10.1016/S1535-6108(02)00082-X", "12150823"]}, {"Citation": "Wang J., He H., Xiang C., Fan X., Yang L., Yuan L., Jiang F., Liu Y. Uncoupling Effect of F16 Is Responsible for Its Mitochondrial Toxicity and Anticancer Activity. Toxicol. Sci. 2018;161:431\u2013442. doi: 10.1093/toxsci/kfx218.", "ArticleIdList": ["10.1093/toxsci/kfx218", "29069523"]}, {"Citation": "Wu S., Cao Q., Wang X., Cheng Z. Design, synthesis and biological evaluation of mitochondria targeting theranostic agents. Chem. Commun. 2014;50:8919\u20138922. doi: 10.1039/C4CC03296A.", "ArticleIdList": ["10.1039/C4CC03296A", "24976119"]}, {"Citation": "Rathinavelu A., Alhazzani K., Kanagasabai T. Anti-cancer effects of F16: A novel vascular endothelial growth factor receptor\u2014Specific inhibitor. Tumor Biol. 2017:1\u201312. doi: 10.1177/1010428317726841.", "ArticleIdList": ["10.1177/1010428317726841", "29130389"]}, {"Citation": "Qian K., Chen H., Qu C., Qi J., Du B., Ko T., Xiang Z., Kandawa-schulz M., Wang Y., Cheng Z. Mitochondria-targeted delocalized lipophilic cation complexed with human serum albumin for tumor cell imaging and treatment. Nanomed. Nanotechnol. Biol. Med. 2020;23:102087. doi: 10.1016/j.nano.2019.102087.", "ArticleIdList": ["10.1016/j.nano.2019.102087", "31454551"]}, {"Citation": "Liu Y.J., Fan X.Y., Zhang D.D., Xia Y.Z., Hu Y.J., Jiang F.L., Zhou F.L., Liu Y. Dual Inhibition of Pyruvate Dehydrogenase Complex and Respiratory Chain Complex Induces Apoptosis by a Mitochondria-Targeted Fluorescent Organic Arsenical in vitro and in vivo. ChemMedChem. 2020;15:552\u2013558. doi: 10.1002/cmdc.201900686.", "ArticleIdList": ["10.1002/cmdc.201900686", "32101363"]}, {"Citation": "Parton R.L., Lenhard J.R., Gilman P.B., Jr. Correlation of Anti-Cancer Activity of Dyes with Redox Potentials. 10,983,369. U.S. Patent. 2006 May 11;"}, {"Citation": "Yang N., Gilman P., Mirzayans R., Sun X., Touret N. Characterization of the Apoptotic Response Induced by the Cyanine Dye D112: A Potentially Selective Anti-Cancer Compound. PLoS ONE. 2015;10:e0125381. doi: 10.1371/journal.pone.0125381.", "ArticleIdList": ["10.1371/journal.pone.0125381", "PMC4415924", "25927702"]}, {"Citation": "Yang N., Weinfeld M., Lemieux H., Montpetit B., Goping I.S. Photo-activation of the delocalized lipophilic cation D112 potentiates cancer selective ROS production and apoptosis. Cell Death Dis. 2017;8:e2587. doi: 10.1038/cddis.2017.19.", "ArticleIdList": ["10.1038/cddis.2017.19", "PMC5386467", "28151485"]}, {"Citation": "Sica V., Bravo-San Pedro J.M., Stoll G., Kroemer G. Oxidative phosphorylation as a potential therapeutic target for cancer therapy. Int. J. Cancer. 2020;146:10\u201317. doi: 10.1002/ijc.32616.", "ArticleIdList": ["10.1002/ijc.32616", "31396957"]}, {"Citation": "Sancho P., Barneda D., Heeschen C. Hallmarks of cancer stem cell metabolism. Br. J. Cancer. 2016;114:1305\u20131312. doi: 10.1038/bjc.2016.152.", "ArticleIdList": ["10.1038/bjc.2016.152", "PMC4984474", "27219018"]}, {"Citation": "Zimorski V., Ku C., Martin W.F., Gould S.B. Endosymbiotic theory for organelle origins. Curr. Opin. Microbiol. 2014;22:38\u201348. doi: 10.1016/j.mib.2014.09.008.", "ArticleIdList": ["10.1016/j.mib.2014.09.008", "25306530"]}, {"Citation": "Esposti M.D., Chouaia B., Comandatore F., Crotti E., Sassera D., Lievens P.M.J., Daffonchio D., Bandi C. Evolution of mitochondria reconstructed from the energy metabolism of living bacteria. PLoS ONE. 2014;9:e96566. doi: 10.1371/journal.pone.0096566.", "ArticleIdList": ["10.1371/journal.pone.0096566", "PMC4013037", "24804722"]}, {"Citation": "Lamb R., Ozsvari B., Lisanti C.L., Tanowitz H.B., Howell A., Martinez-Outschoorn U.E., Sotgia F., Lisanti M.P. Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease. Oncotarget. 2015;6:4569\u20134584. doi: 10.18632/oncotarget.3174.", "ArticleIdList": ["10.18632/oncotarget.3174", "PMC4467100", "25625193"]}, {"Citation": "Smith R.A.J., Porteous C.M., Coulter C.V., Murphy M.P. Selective targeting of an antioxidant to mitochondria. Eur. J. Biochem. 1999;716:709\u2013716. doi: 10.1046/j.1432-1327.1999.00543.x.", "ArticleIdList": ["10.1046/j.1432-1327.1999.00543.x", "10469134"]}, {"Citation": "Dhanasekaran A., Kotamraju S., Kalivendi S.V., Matsunaga T., Shang T., Keszler A., Joseph J., Kalyanaraman B. Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis. J. Biol. Chem. 2004;279:37575\u201337587. doi: 10.1074/jbc.M404003200.", "ArticleIdList": ["10.1074/jbc.M404003200", "15220329"]}, {"Citation": "Peredo-silva L., Fuentes-retamal S., Sandoval-acu\u00f1a C., Pavani M., Maya J.D., Castro-castillo V., Madrid-rojas M., Rebolledo S., Kemmerling U., Parra E., et al. Derivatives of alkyl gallate triphenylphosphonium exhibit antitumor activity in a syngeneic murine model of mammary adenocarcinoma. Toxicol. Appl. Pharmacol. 2017;329:334\u2013346. doi: 10.1016/j.taap.2017.06.017.", "ArticleIdList": ["10.1016/j.taap.2017.06.017", "28647477"]}, {"Citation": "Han M., Vakili M.R., Soleymani Abyaneh H., Molavi O., Lai R., Lavasanifar A. Mitochondrial delivery of doxorubicin via triphenylphosphine modification for overcoming drug resistance in MDA-MB-435/DOX cells. Mol. Pharm. 2014;11:2640\u20132649. doi: 10.1021/mp500038g.", "ArticleIdList": ["10.1021/mp500038g", "24811541"]}, {"Citation": "Millard M., Gallagher J.D., Olenyuk B.Z., Neamati N. A selective mitochondrial-targeted chlorambucil with remarkable cytotoxicity in breast and pancreatic cancers. J. Med. Chem. 2013;56:9170\u20139179. doi: 10.1021/jm4012438.", "ArticleIdList": ["10.1021/jm4012438", "24147900"]}, {"Citation": "Blaikie F.H., Brown S.E., Samuelsson L.M., Brand M.D., Smith R.A.J., Murphy M.P. Targeting dinitrophenol to mitochondria: Limitations to the development of a self-limiting mitochondrial protonophore. Biosci. Rep. 2006;26:231\u2013243. doi: 10.1007/s10540-006-9018-8.", "ArticleIdList": ["10.1007/s10540-006-9018-8", "16850251"]}, {"Citation": "Cheng G., Zhang Q., Pan J., Lee Y., Ouari O., Hardy M., Zielonka M., Myers C.R., Zielonka J., Weh K., et al. Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis. Nat. Commun. 2019;10:2205. doi: 10.1038/s41467-019-10042-1.", "ArticleIdList": ["10.1038/s41467-019-10042-1", "PMC6525201", "31101821"]}, {"Citation": "Cheng G., Zielonka J., Ouari O., Lopez M., McAllister D., Boyle K., Barrios C.S., Weber J.J., Johnson B.D., Hardy M., et al. Mitochondria-targeted analogues of metformin exhibit enhanced antiproliferative and radiosensitizing effects in pancreatic cancer cells. Cancer Res. 2016;76:3904\u20133915. doi: 10.1158/0008-5472.CAN-15-2534.", "ArticleIdList": ["10.1158/0008-5472.CAN-15-2534", "PMC4930686", "27216187"]}, {"Citation": "Chowdhury A.R., Zielonka J., Kalyanaraman B., Hartley R.C., Murphy M.P., Avadhani N.G. Mitochondria-targeted paraquat and metformin mediate ROS production to induce multiple pathways of retrograde signaling: A dose-dependent phenomenon. Redox Biol. 2020;36:101606. doi: 10.1016/j.redox.2020.101606.", "ArticleIdList": ["10.1016/j.redox.2020.101606", "PMC7327929", "32604037"]}, {"Citation": "Sun C., Cao Y., Zhu P., Zhou B. A mitochondria-targeting artemisinin derivative with sharply increased antitumor but depressed anti-yeast and anti-malaria activities. Sci. Rep. 2017;7:45665. doi: 10.1038/srep45665.", "ArticleIdList": ["10.1038/srep45665", "PMC5377301", "28368011"]}, {"Citation": "Reddy C.A., Somepalli V., Golakoti T., Kanugula A.K.R., Karnewar S., Rajendiran K., Vasagiri N., Prabhakar S., Kuppusamy P., Kotamraju S., et al. Mitochondrial-targeted curcuminoids: A strategy to enhance bioavailability and anticancer efficacy of curcumin. PLoS ONE. 2014;9:e89351. doi: 10.1371/journal.pone.0089351.", "ArticleIdList": ["10.1371/journal.pone.0089351", "PMC3951186", "24622734"]}, {"Citation": "Hasan W., Kori R.K., Thakre K., Yadav R.S., Jat D. Synthesis, characterization and efficacy of mitochondrial targeted delivery of TPP-curcumin in rotenone-induced toxicity. DARU J. Pharm. Sci. 2019;27:557\u2013570. doi: 10.1007/s40199-019-00283-2.", "ArticleIdList": ["10.1007/s40199-019-00283-2", "PMC6895339", "31264184"]}, {"Citation": "Protasoni M., Kroon A.M., Taanman J.W. Mitochondria as oncotarget: A comparison between the tetracycline analogs doxycycline and COL-3. Oncotarget. 2018;9:33818\u201333831. doi: 10.18632/oncotarget.26107.", "ArticleIdList": ["10.18632/oncotarget.26107", "PMC6173462", "30333912"]}, {"Citation": "Dijk S.N., Protasoni M., Elpidorou M., Kroon A.M., Taanman J.W. Mitochondria as target to inhibit proliferation and induce apoptosis of cancer cells: The effects of doxycycline and gemcitabine. Sci. Rep. 2020;10:4363. doi: 10.1038/s41598-020-61381-9.", "ArticleIdList": ["10.1038/s41598-020-61381-9", "PMC7063048", "32152409"]}, {"Citation": "Fiorillo M., T\u00f3th F., Sotgia F., Lisanti M.P. Doxycycline, Azithromycin and vitamin C (DAV): A potent combination therapy for targeting mitochondria and eradicating cancer stem cells (CSCs) Aging. 2019;11:2202\u20132216. doi: 10.18632/aging.101905.", "ArticleIdList": ["10.18632/aging.101905", "PMC6520007", "31002656"]}, {"Citation": "Song H., Fares M., Maguire K.R., Sid\u00e9n \u00c5., Pot\u00e1cov\u00e1 Z. Cytotoxic effects of tetracycline analogues (doxycycline, minocycline and COL-3) in acute Myeloid leukemia HL-60 cells. PLoS ONE. 2014;9:e114457. doi: 10.1371/journal.pone.0114457.", "ArticleIdList": ["10.1371/journal.pone.0114457", "PMC4266609", "25502932"]}, {"Citation": "Rok J., Karkoszka M., Rzepka Z., Respondek M., Banach K., Beberok A., Wrze\u015bniok D. Cytotoxic and proapoptotic effect of doxycycline\u2014An in vitro study on the human skin melanoma cells. Toxicol. In Vitro. 2020;65 doi: 10.1016/j.tiv.2020.104790.", "ArticleIdList": ["10.1016/j.tiv.2020.104790", "32044399"]}, {"Citation": "Fuentes-Retamal S., Sandoval-Acu\u00f1a C., Peredo-Silva L., Guzm\u00e1n-Rivera D., Pavani M., Torrealba N., Truksa J., Castro-Castillo V., Catal\u00e1n M., Kemmerling U., et al. Complex Mitochondrial Dysfunction Induced by TPP+-Gentisic Acid and Mitochondrial Translation Inhibition by Doxycycline Evokes Synergistic Lethality in Breast Cancer Cells. Cells. 2020;9:407. doi: 10.3390/cells9020407.", "ArticleIdList": ["10.3390/cells9020407", "PMC7072465", "32053908"]}, {"Citation": "Scatena C., Roncella M., Di Paolo A., Aretini P., Menicagli M., Fanelli G., Marini C., Mazzanti C.M., Ghilli M., Sotgia F., et al. Doxycycline, an inhibitor of mitochondrial biogenesis, effectively reduces cancer stem cells (CSCs) in early breast cancer patients: A clinical pilot study. Front. Oncol. 2018;8:452. doi: 10.3389/fonc.2018.00452.", "ArticleIdList": ["10.3389/fonc.2018.00452", "PMC6194352", "30364293"]}, {"Citation": "Zhang L., Xu L., Zhang F., Vlashi E. Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer. Cell Cycle. 2017;16:737\u2013745. doi: 10.1080/15384101.2016.1241929.", "ArticleIdList": ["10.1080/15384101.2016.1241929", "PMC5405729", "27753527"]}, {"Citation": "Wang Y., Xie F., Chen D., Wang L. Inhibition of mitochondrial respiration by tigecycline selectively targets thyroid carcinoma and increases chemosensitivity. Clin. Exp. Pharmacol. Physiol. 2019;46:890\u2013897. doi: 10.1111/1440-1681.13126.", "ArticleIdList": ["10.1111/1440-1681.13126", "31209921"]}, {"Citation": "Jia X., Gu Z., Chen W., Jiao J. Tigecycline targets nonsmall cell lung cancer through inhibition of mitochondrial function. Fundam. Clin. Pharmacol. 2016;30:297\u2013306. doi: 10.1111/fcp.12199.", "ArticleIdList": ["10.1111/fcp.12199", "27009695"]}, {"Citation": "Tan J., Song M., Zhou M., Hu Y. Antibiotic tigecycline enhances cisplatin activity against human hepatocellular carcinoma through inducing mitochondrial dysfunction and oxidative damage. Biochem. Biophys. Res. Commun. 2017;483:17\u201323. doi: 10.1016/j.bbrc.2017.01.021.", "ArticleIdList": ["10.1016/j.bbrc.2017.01.021", "28069382"]}, {"Citation": "Lu Z., Xu N., He B., Pan C., Lan Y., Zhou H., Liu X. Inhibition of autophagy enhances the selective anti-cancer activity of tigecycline to overcome drug resistance in the treatment of chronic myeloid leukemia. J. Exp. Clin. Cancer Res. 2017;36:43. doi: 10.1186/s13046-017-0512-6.", "ArticleIdList": ["10.1186/s13046-017-0512-6", "PMC5345227", "28283035"]}, {"Citation": "Kuntz E.M., Baquero P., Michie A.M., Dunn K., Tardito S. Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemic stem cells. Nat. Med. 2018;23:1234\u20131240. doi: 10.1038/nm.4399.", "ArticleIdList": ["10.1038/nm.4399", "PMC5657469", "28920959"]}, {"Citation": "Bindu S., Mazumder S., Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem. Pharmacol. 2020;180:114147. doi: 10.1016/j.bcp.2020.114147.", "ArticleIdList": ["10.1016/j.bcp.2020.114147", "PMC7347500", "32653589"]}, {"Citation": "Sun Y., Huang L., Mackenzie G.G., Rigas B. Oxidative stress mediates through apoptosis the anticancer effect of phospho-nonsteroidal anti-inflammatory drugs: Implications for the role of oxidative stress in the action of anticancer agents. J. Pharmacol. Exp. Ther. 2011;338:775\u2013783. doi: 10.1124/jpet.111.183533.", "ArticleIdList": ["10.1124/jpet.111.183533", "PMC3164348", "21646387"]}, {"Citation": "Raza H., John A., Benedict S. Acetylsalicylic acid-induced oxidative stress, cell cycle arrest, apoptosis and mitochondrial dysfunction in human hepatoma HepG2 cells. Eur. J. Pharmacol. 2011;668:15\u201324. doi: 10.1016/j.ejphar.2011.06.016.", "ArticleIdList": ["10.1016/j.ejphar.2011.06.016", "21722632"]}, {"Citation": "Suzuki Y., Inoue T., Ra C. NSAIDs, mitochondria and calcium signaling: Special focus on aspirin/salicylates. Pharmaceuticals. 2010;3:1594\u20131613. doi: 10.3390/ph3051594.", "ArticleIdList": ["10.3390/ph3051594", "PMC4033999", "27713319"]}, {"Citation": "Tewari D., Majumdar D., Vallabhaneni S., Bera A.K. Aspirin induces cell death by directly modulating mitochondrial voltage-dependent anion channel (VDAC) Sci. Rep. 2017;7:45184. doi: 10.1038/srep45184.", "ArticleIdList": ["10.1038/srep45184", "PMC5361111", "28327594"]}, {"Citation": "Bank A., Yu J., Zhang L. NSAIDs downregulate Bcl-XL and dissociate BAX and Bcl-X L to induce apoptosis in colon cancer cells. Nutr. Cancer. 2008;60:98\u2013103. doi: 10.1080/01635580802381261.", "ArticleIdList": ["10.1080/01635580802381261", "19003586"]}, {"Citation": "Chen J., Xu R., Xia J., Huang J., Su B., Wang S. Aspirin inhibits hypoxia-mediated lung cancer cell stemness and exosome function. Pathol. Res. Pract. 2019;215:152379. doi: 10.1016/j.prp.2019.03.008.", "ArticleIdList": ["10.1016/j.prp.2019.03.008", "30878308"]}, {"Citation": "Chen Z., Li W., Qiu F., Huang Q., Jiang Z., Ye J., Cheng P., Low C., Guo Y., Yi X., et al. Aspirin cooperates with p300 to activate the acetylation of H3K9 and promote FasL-mediated apoptosis of cancer stem-like cells in colorectal cancer. Theranostics. 2018;8:4447\u20134461. doi: 10.7150/thno.24284.", "ArticleIdList": ["10.7150/thno.24284", "PMC6134920", "30214631"]}, {"Citation": "Pritchard R., Rodr\u00edguez-Enr\u00edquez S., Pacheco-Vel\u00e1zquez S.C., Bortnik V., Moreno-S\u00e1nchez R., Ralph S. Celecoxib inhibits mitochondrial O2 consumption, promoting ROS dependent death of murine and human metastatic cancer cells via the apoptotic signalling pathway. Biochem. Pharmacol. 2018;154:318\u2013334. doi: 10.1016/j.bcp.2018.05.013.", "ArticleIdList": ["10.1016/j.bcp.2018.05.013", "29800556"]}, {"Citation": "Amanullah A., Mishra R., Upadhyay A., Reddy P.P., Das R., Mishra A. Indomethacin elicits proteasomal dysfunctions develops apoptosis through mitochondrial abnormalities. J. Cell. Physiol. 2018;233:1685\u20131699. doi: 10.1002/jcp.26081.", "ArticleIdList": ["10.1002/jcp.26081", "28681929"]}, {"Citation": "Mazumder S., De R., Debsharma S., Bindu S., Maity P., Sarkar S., Saha S.J., Siddiqui A.A., Banerjee C., Nag S., et al. Indomethacin impairs mitochondrial dynamics by activating the PKC\u03b6-p38-DRP1 pathway and inducing apoptosis in gastric cancer and normal mucosal cells. J. Biol. Chem. 2019;294:8238\u20138258. doi: 10.1074/jbc.RA118.004415.", "ArticleIdList": ["10.1074/jbc.RA118.004415", "PMC6527165", "30940726"]}, {"Citation": "Scatena R., Bottoni P., Giardina B. Mitochondria, PPARs, and cancer: Is receptor-independent action of PPAR agonists a key? PPAR Res. 2008;2008 doi: 10.1155/2008/256251.", "ArticleIdList": ["10.1155/2008/256251", "PMC2464819", "18645611"]}, {"Citation": "Wilk A., Wyczechowska D., Zapata A., Dean M., Mullinax J., Marrero L., Parsons C., Peruzzi F., Culicchia F., Ochoa A., et al. Molecular mechanisms of fenofibrate-induced metabolic catastrophe and glioblastoma cell death. Mol. Cell. Biol. 2015;35:182\u2013198. doi: 10.1128/MCB.00562-14.", "ArticleIdList": ["10.1128/MCB.00562-14", "PMC4295376", "25332241"]}, {"Citation": "Chen L., Peng J., Wang Y., Jiang H., Wang W., Dai J., Tang M., Wei Y., Kuang H., Xu G., et al. Fenofibrate-induced mitochondrial dysfunction and metabolic reprogramming reversal: The anti-tumor effects in gastric carcinoma cells mediated by the PPAR pathway. Am. J. Transl. Res. 2020;12:428\u2013446.", "ArticleIdList": ["PMC7061836", "32194894"]}, {"Citation": "Du Souich P., Roederer G., Dufour R. Myotoxicity of statins: Mechanism of action. Pharmacol. Ther. 2017;175:1\u201316. doi: 10.1016/j.pharmthera.2017.02.029.", "ArticleIdList": ["10.1016/j.pharmthera.2017.02.029", "28223230"]}, {"Citation": "Christie C.F., Fang D., Hunt E.G., Morris M.E., Rovini A., Heslop K.A., Beeson G.C., Beeson C.C., Maldonado E.N. Statin-dependent modulation of mitochondrial metabolism in cancer cells is independent of cholesterol content. FASEB J. 2019;33:8186\u20138201. doi: 10.1096/fj.201802723R.", "ArticleIdList": ["10.1096/fj.201802723R", "PMC6593894", "30951369"]}, {"Citation": "Lee M.-H., Cho Y.S., Han Y.-M. Simvastatin Suppresses Self-Renewal of Mouse Embryonic Stem Cells by Inhibiting RhoA Geranylgeranylation. Stem Cells. 2007;25:1654\u20131663. doi: 10.1634/stemcells.2006-0753.", "ArticleIdList": ["10.1634/stemcells.2006-0753", "17464088"]}, {"Citation": "Wang C., Li P., Xuan J., Zhu C., Liu J., Shan L., Du Q., Ren Y., Ye J. Cholesterol Enhances Colorectal Cancer Progression via ROS Elevation and MAPK Signaling Pathway Activation. Cell. Physiol. Biochem. 2017;42:729\u2013742. doi: 10.1159/000477890.", "ArticleIdList": ["10.1159/000477890", "28618417"]}, {"Citation": "Gauthaman K., Fong C.Y., Bongso A. Statins, stem cells, and cancer. J. Cell. Biochem. 2009;106:975\u2013983. doi: 10.1002/jcb.22092.", "ArticleIdList": ["10.1002/jcb.22092", "19224538"]}, {"Citation": "Likus W., Siemianowicz K., Bie\u0144k K., Paku\u0142a M., Pathak H., Dutta C., Wang Q., Shojaei S., Assaraf Y.G., Ghavami S., et al. Could drugs inhibiting the mevalonate pathway also target cancer stem cells? Drug Resist. Updates. 2016;25:13\u201325. doi: 10.1016/j.drup.2016.02.001.", "ArticleIdList": ["10.1016/j.drup.2016.02.001", "27155373"]}, {"Citation": "Mok E.H.K., Lee T.K.W. The pivotal role of the dysregulation of cholesterol homeostasis in cancer: Implications for therapeutic targets. Cancers. 2020;12:1410. doi: 10.3390/cancers12061410.", "ArticleIdList": ["10.3390/cancers12061410", "PMC7352357", "32486083"]}, {"Citation": "Hwang H., Ryu D.H., Hwang G., Cheong J. Integrated omics-analysis reveals Wnt-mediated metabolic reprogramming in cancer stem-like cells. Oncotarget. 2016;7:48562\u201348576.", "ArticleIdList": ["PMC5217038", "27391070"]}, {"Citation": "Shin M.K., Cheong J.H. Mitochondria-centric bioenergetic characteristics in cancer stem-like cells. Arch. Pharm. Res. 2019;42:113\u2013127. doi: 10.1007/s12272-019-01127-y.", "ArticleIdList": ["10.1007/s12272-019-01127-y", "PMC6399179", "30771209"]}, {"Citation": "Bridges H.R., Jones A.J.Y., Pollak M.N., Hirst J. Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria. Biochem. J. 2014;462:475\u2013487. doi: 10.1042/BJ20140620.", "ArticleIdList": ["10.1042/BJ20140620", "PMC4148174", "25017630"]}, {"Citation": "Wheaton W.W., Weinberg S.E., Hamanaka R.B., Soberanes S., Sullivan L.B., Anso E., Glasauer A., Dufour E., Mutlu G.M., Scott Budigner G.R., et al. Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis. eLife. 2014;3:e02242. doi: 10.7554/eLife.02242.", "ArticleIdList": ["10.7554/eLife.02242", "PMC4017650", "24843020"]}, {"Citation": "Fontaine E. Metformin-Induced Mitochondrial Complex I Inhibition: Facts, Uncertainties, and Consequences. Front. Endocrinol. 2018;9:23\u201328. doi: 10.3389/fendo.2018.00753.", "ArticleIdList": ["10.3389/fendo.2018.00753", "PMC6304344", "30619086"]}, {"Citation": "Droguett D., Castillo C., Leiva E., Theoduloz C., Schmeda G., Kemmerling U. Efficacy of quercetin against chemically induced murine oral squamous cell carcinoma. Oncol. Lett. 2015;10:2432\u20132438. doi: 10.3892/ol.2015.3598.", "ArticleIdList": ["10.3892/ol.2015.3598", "PMC4580003", "26622865"]}, {"Citation": "Hirsch H.A., Iliopoulos D., Tsichlis P.N., Struhl K. Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res. 2009;69:7507\u20137511. doi: 10.1158/0008-5472.CAN-09-2994.", "ArticleIdList": ["10.1158/0008-5472.CAN-09-2994", "PMC2756324", "19752085"]}, {"Citation": "Sonnenblick A., Agbor-Tarh D., Bradbury I., Di Cosimo S., Azim H.A., Fumagalli D., Sarp S., Wolff A.C., Andersson M., Kroep J., et al. Impact of diabetes, insulin, and metformin use on the outcome of patients with human epidermal growth factor receptor 2-positive primary breast cancer: Analysis from the ALTTO phase III randomized trial. J. Clin. Oncol. 2017;35:1421\u20131429. doi: 10.1200/JCO.2016.69.7722.", "ArticleIdList": ["10.1200/JCO.2016.69.7722", "PMC5455460", "28375706"]}, {"Citation": "Chae Y.K., Arya A., Malecek M.K., Shin D.S., Carneiro B., Chandra S., Kaplan J., Kalyan A., Altman J.K., Platanias L., et al. Repurposing metformin for cancer treatment: Current clinical studies. Oncotarget. 2016;7:40767\u201340780. doi: 10.18632/oncotarget.8194.", "ArticleIdList": ["10.18632/oncotarget.8194", "PMC5130043", "27004404"]}]}], "History": [{"Year": "2020", "Month": "10", "Day": "21"}, {"Year": "2020", "Month": "11", "Day": "10"}, {"Year": "2020", "Month": "11", "Day": "12"}, {"Year": "2020", "Month": "11", "Day": "21", "Hour": "1", "Minute": "0"}, {"Year": "2020", "Month": "11", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "11", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["33217901", "PMC7698797", "10.3390/ijms21228684", "ijms21228684"]}}]}